- Home
- KALV vs NGS Comparison
KALV vs NGS Comparison
Compare KALV & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- NGS
- Stock Information
- Founded
- KALV N/A
- NGS 1998
- Country
- KALV United States
- NGS United States
- Employees
- KALV N/A
- NGS N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- NGS Oilfield Services/Equipment
- Sector
- KALV Health Care
- NGS Energy
- Exchange
- KALV Nasdaq
- NGS Nasdaq
- Market Cap
- KALV 362.2M
- NGS 326.3M
- IPO Year
- KALV N/A
- NGS 2002
- Fundamental
- Price
- KALV $10.03
- NGS $26.47
- Analyst Decision
- KALV Strong Buy
- NGS Strong Buy
- Analyst Count
- KALV 8
- NGS 2
- Target Price
- KALV $25.67
- NGS $26.50
- AVG Volume (30 Days)
- KALV 321.8K
- NGS 62.2K
- Earning Date
- KALV 03-10-2025
- NGS 03-31-2025
- Dividend Yield
- KALV N/A
- NGS N/A
- EPS Growth
- KALV N/A
- NGS 605.21
- EPS
- KALV N/A
- NGS 1.28
- Revenue
- KALV N/A
- NGS $152,305,000.00
- Revenue This Year
- KALV N/A
- NGS $30.81
- Revenue Next Year
- KALV N/A
- NGS $13.48
- P/E Ratio
- KALV N/A
- NGS $21.43
- Revenue Growth
- KALV N/A
- NGS 41.72
- 52 Week Low
- KALV $7.30
- NGS $15.31
- 52 Week High
- KALV $15.50
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- KALV 59.09
- NGS 45.87
- Support Level
- KALV $8.99
- NGS $25.45
- Resistance Level
- KALV $11.00
- NGS $28.13
- Average True Range (ATR)
- KALV 0.57
- NGS 1.01
- MACD
- KALV 0.11
- NGS 0.01
- Stochastic Oscillator
- KALV 57.08
- NGS 39.19
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.